{"id":"https://openalex.org/W2167480327","doi":"https://doi.org/10.1073/pnas.0806669105","title":"Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs","display_name":"Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs","alternate_titles":[],"publication_year":2008,"publication_date":"2008-11-18","ids":{"openalex":"https://openalex.org/W2167480327","doi":"https://doi.org/10.1073/pnas.0806669105","mag":"2167480327","pmid":"https://pubmed.ncbi.nlm.nih.gov/19004793","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2584724"},"language":"en","primary_location":{"id":"doi:10.1073/pnas.0806669105","doi":"https://doi.org/10.1073/pnas.0806669105","is_oa":false,"landing_page_url":"https://doi.org/10.1073/pnas.0806669105","pdf_url":null,"source":{"id":"https://openalex.org/S125754415","display_name":"Proceedings of the National Academy of Sciences","issn_l":"0027-8424","issn":["0027-8424","1091-6490"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320052","host_organization_name":"National Academy of Sciences","host_organization_lineage":["https://openalex.org/P4310320052"],"host_organization_lineage_names":["National Academy of Sciences"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2167480327"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2584724/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081331038","display_name":"Houman Homayoun","orcid":"https://orcid.org/0000-0001-5458-8338","observed_orcids":["https://orcid.org/0000-0001-5458-8338"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Houman Homayoun","raw_affiliation_strings":["Department of Neuroscience, University of Pittsburgh, A210 Langley Hall, Pittsburgh, PA 15260","University of Oxford, Oxford, United Kingdom,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, University of Pittsburgh, A210 Langley Hall, Pittsburgh, PA 15260","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"University of Oxford, Oxford, United Kingdom,","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055349297","display_name":"Bita Moghaddam","orcid":"https://orcid.org/0000-0002-5205-417X","observed_orcids":["https://orcid.org/0000-0002-5205-417X"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bita Moghaddam","raw_affiliation_strings":["Department of Neuroscience, University of Pittsburgh, A210 Langley Hall, Pittsburgh, PA 15260","University of Oxford, Oxford, United Kingdom,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, University of Pittsburgh, A210 Langley Hall, Pittsburgh, PA 15260","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"University of Oxford, Oxford, United Kingdom,","institution_ids":["https://openalex.org/I40120149"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.6388,"has_fulltext":false,"cited_by_count":85,"citation_normalized_percentile":{"value":0.94278091,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"105","issue":"46","first_page":"18041","last_page":"18046"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.009200000204145908,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orbitofrontal-cortex","display_name":"orbitofrontal cortex","score":0.9700000286102295},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.878000020980835},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9610000252723694},{"id":"https://openalex.org/keywords/mglu2-3-receptor-agonists","display_name":"mGlu2/3 receptor agonists","score":0.8539999723434448},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9649999737739563},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":1.0},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.6610000133514404},{"id":"https://openalex.org/keywords/amphetamine","display_name":"amphetamine","score":0.949999988079071},{"id":"https://openalex.org/keywords/gabaergic-interneurons","display_name":"GABAergic interneurons","score":0.8289999961853027},{"id":"https://openalex.org/keywords/pyramidal-neurons","display_name":"pyramidal neurons","score":0.8040000200271606},{"id":"https://openalex.org/keywords/stereotyped-behavior","display_name":"stereotypy","score":0.6990000009536743},{"id":"https://openalex.org/keywords/prefrontal-cortex","display_name":"prefrontal cortex","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6307495832443237},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5529555678367615},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5472776293754578},{"id":"https://openalex.org/C26702167","wikidata":"https://www.wikidata.org/wiki/Q901988","display_name":"Metabotropic receptor","level":4,"score":0.47791987657546997},{"id":"https://openalex.org/C2776559556","wikidata":"https://www.wikidata.org/wiki/Q18717","display_name":"Orbitofrontal cortex","level":4,"score":0.47676926851272583},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.47173988819122314},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.4524104595184326},{"id":"https://openalex.org/C2775870346","wikidata":"https://www.wikidata.org/wiki/Q2554162","display_name":"Typical antipsychotic","level":5,"score":0.44402509927749634},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.443552166223526},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.4233267307281494},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.41918396949768066},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4049524962902069},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.3960303068161011},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3951619863510132},{"id":"https://openalex.org/C2781195155","wikidata":"https://www.wikidata.org/wiki/Q18680","display_name":"Prefrontal cortex","level":3,"score":0.38661307096481323},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3581943213939667},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29823601245880127},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.25625666975975037},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.22528094053268433},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21728530526161194},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.14888766407966614},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005971","descriptor_name":"Glutamates","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008564","descriptor_name":"Membrane Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D013239","descriptor_name":"Stereotyped Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D017397","descriptor_name":"Prefrontal Cortex","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1073/pnas.0806669105","doi":"https://doi.org/10.1073/pnas.0806669105","is_oa":false,"landing_page_url":"https://doi.org/10.1073/pnas.0806669105","pdf_url":null,"source":{"id":"https://openalex.org/S125754415","display_name":"Proceedings of the National Academy of Sciences","issn_l":"0027-8424","issn":["0027-8424","1091-6490"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320052","host_organization_name":"National Academy of Sciences","host_organization_lineage":["https://openalex.org/P4310320052"],"host_organization_lineage_names":["National Academy of Sciences"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2584724","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2584724/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proc Natl Acad Sci U S A","raw_type":"Text"},{"id":"pmid:19004793","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19004793","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences of the United States of America","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2584724","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2584724/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proc Natl Acad Sci U S A","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G700449668","display_name":"Neurochemical Effects of Antipsychotic Drugs","funder_award_id":"R37MH048404","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G9000901621","display_name":"Neural basis of learning and response inhibition in adolescents","funder_award_id":"R01MH048404","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W1482139424","https://openalex.org/W1493618805","https://openalex.org/W1514487637","https://openalex.org/W1959149129","https://openalex.org/W1965790905","https://openalex.org/W1967443916","https://openalex.org/W1969273085","https://openalex.org/W1970448316","https://openalex.org/W1970596941","https://openalex.org/W1973476733","https://openalex.org/W1989728587","https://openalex.org/W1990956863","https://openalex.org/W1993586476","https://openalex.org/W2010547854","https://openalex.org/W2011408679","https://openalex.org/W2015161406","https://openalex.org/W2017011655","https://openalex.org/W2022809683","https://openalex.org/W2023316520","https://openalex.org/W2025240330","https://openalex.org/W2026511950","https://openalex.org/W2029755348","https://openalex.org/W2030143818","https://openalex.org/W2037032780","https://openalex.org/W2040545532","https://openalex.org/W2042393535","https://openalex.org/W2046037125","https://openalex.org/W2063505213","https://openalex.org/W2071090720","https://openalex.org/W2071790368","https://openalex.org/W2080811986","https://openalex.org/W2082483237","https://openalex.org/W2087566431","https://openalex.org/W2089912569","https://openalex.org/W2092353580","https://openalex.org/W2116386279","https://openalex.org/W2120063529","https://openalex.org/W2123856966","https://openalex.org/W2127057918","https://openalex.org/W2127679160","https://openalex.org/W2134806750","https://openalex.org/W2136925527","https://openalex.org/W2137774390","https://openalex.org/W2140506009","https://openalex.org/W2142167282","https://openalex.org/W2145308745","https://openalex.org/W2147802660","https://openalex.org/W2153361867","https://openalex.org/W2161639666","https://openalex.org/W2161641617","https://openalex.org/W2162121368","https://openalex.org/W2476998615","https://openalex.org/W2955504961","https://openalex.org/W4231984716","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W939249341","https://openalex.org/W1580988899","https://openalex.org/W2017011655","https://openalex.org/W122719033","https://openalex.org/W2017151426","https://openalex.org/W2000520286","https://openalex.org/W2125232095","https://openalex.org/W2111521524","https://openalex.org/W1524563580","https://openalex.org/W2084967021"],"abstract_inverted_index":{"Until":[0],"recently,":[1],"all":[2],"known":[3],"antipsychotic":[4,184,218,251],"drugs":[5,162,219],"were":[6,210],"thought":[7],"to":[8,46,89,182],"block":[9],"the":[10,19,53,58,69,91,104,112,187,227,247],"dopamine":[11,137,233],"D2":[12],"receptor.":[13],"New":[14],"evidence":[15],"that":[16,33,51,64,95,239],"agonists":[17],"of":[18,30,55,71,106,114,126,147,153,189,201,203,223,229,250],"metabotropic":[20],"glutamate":[21],"2/3":[22],"(mGlu2/3)":[23],"receptors":[24],"ameliorate":[25],"psychotic":[26],"and":[27,119,142,164,176,195,232],"affective":[28],"symptoms":[29],"schizophrenia":[31,141],"suggests":[32],"compounds":[34],"with":[35,84,220],"different":[36,150,221],"molecular":[37],"targets":[38],"may":[39,96],"act":[40],"on":[41,192,196,235],"a":[42,62,75,85,136,145,243],"common":[43],"cellular":[44],"target":[45,167,245],"treat":[47],"schizophrenia.":[48,99],"We":[49,77],"hypothesized":[50],"normalizing":[52],"activity":[54,80,105,113,205],"neurons":[56,241],"in":[57,68,81,98,140,156],"orbitofrontal":[59],"cortex":[60,159],"(OFC),":[61],"region":[63],"is":[65],"increasingly":[66],"implicated":[67],"pathophysiology":[70],"schizophrenia,":[72],"presents":[73],"such":[74],"target.":[76],"disrupted":[78],"OFC":[79,127,193,204,236],"behaving":[82],"rats":[83],"use-dependent":[86],"NMDA":[87,92,154,190,230],"antagonist":[88],"model":[90],"hypofunction":[93,191,231],"state":[94,139],"occur":[97],"This":[100],"systemic":[101],"treatment":[102],"increased":[103],"most":[107],"pyramidal":[108],"cells":[109,194],"while":[110],"inhibiting":[111],"putative":[115,217],"inhibitory":[116],"GABA":[117],"interneurons":[118],"increasing":[120],"behavioral":[121],"stereotypy.":[122],"A":[123,198],"similar":[124,199],"pattern":[125,146,200],"firing":[128,148],"disruption":[129,149],"was":[130,206],"observed":[131,207],"after":[132,212],"amphetamine,":[133],"which":[134,143,166],"models":[135],"hyperactivity":[138],"produces":[144],"from":[151],"those":[152],"antagonists":[155],"other":[157],"prefrontal":[158],"regions.":[160],"Antipsychotic":[161],"haloperidol":[163],"clozapine,":[165],"monoamine":[168],"receptors,":[169],"as":[170,172],"well":[171],"an":[173,177],"mGlu2/3":[174],"agonist":[175],"mGlu5":[178],"receptor":[179],"modulator":[180],"proposed":[181],"have":[183],"efficacy,":[185],"reversed":[186],"impact":[188,228],"behavior.":[197],"normalization":[202],"when":[208],"treatments":[209],"given":[211],"amphetamine.":[213],"Thus,":[214],"proven":[215],"or":[216],"mechanisms":[222],"action":[224],"similarly":[225],"reduced":[226],"hyperfunction":[234],"neurons,":[237],"suggesting":[238],"these":[240],"are":[242],"candidate":[244],"for":[246],"therapeutic":[248],"effects":[249],"medications.":[252]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2167480327","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
